Showing results 1 to 4 of 4
Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4![]() Kim, Solbi; Ko, Dongjoon; Lee, Yunhee; Jang, Seonghui; Lee, Younghoon; Lee, Ill Young; Kim, Semi, SCIENTIFIC REPORTS, v.9, 2019-07 |
Discovery of a novel NUAK1 inhibitor against pancreatic cancer Seo, Myeong-Seong; Jung, Kyung Hee; Kim, Kewon; Lee, Ji Eun; Han, Beom Seok; Ko, Soyeon; Kim, Jae Ho; et al, BIOMEDICINE & PHARMACOTHERAPY, v.152, 2022-08 |
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1 Lee, Yunhee; Ko, Dongjoon; Min, Hye-Jin; Kim, Sol Bi; Ahn, Hye-Mi; Lee, Younghoon; Kim, Semi, ONCOTARGET, v.7, no.31, pp.50315 - 50332, 2016-08 |
Discover